传统的医院里光照有一定效果，现在临床试验IL-17抑制剂有疗效（见内）

来源: 杨别青 于 2021-07-12 20:03:12 [] [博客] [旧帖] [给我悄悄话] 阅读数 : (18854 bytes)
本帖于 2021-07-14 16:14:41 时间, 由普通用户 杨别青 编辑
回答: 美国有什么药治白癜风吗？ 由 twodoggys 于 2021-07-10 20:54:52
https://patents.google.com/patent/WO2017221174A1/en

Methods of treating vitiligo using interleukin-17 (il-17) antibodies

 

Abstract
The present disclosure relates to methods for treating vitiligo using IL-17 antagonists, e.g., secukinumab. Also disclosed herein are uses of IL-17 antagonists, e.g., IL-17 antibodies, such as secukinumab, for treating vitiligo patients, as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the disclosed uses and methods.
 

 

Classifications
 C07K16/244 Interleukins [IL]
View 5 more classifications

WO2017221174A1

WIPO (PCT)

 Download PDF  Find Prior Art  Similar
Other languages
French
Inventor
Joel Gelfand
Worldwide applications
2017  WO
Application PCT/IB2017/053701 events 
2016-06-22
 
Priority to US201662353121P
2016-06-22
 
Priority to US62/353,121
2017-06-21
 
Application filed by Novartis Ag
2017-12-28
 
Publication of WO2017221174A1
Info
Patent citations (9)
 
Non-patent citations (27)
 
Cited by (1)
 
Legal events
 
Similar documents
 
Priority and Related Applications
External links
Espacenet
Global Dossier
PatentScope
Discuss

 

Description
METHODS OF TREATING VITILIGO USING INTERLEUKIN-17 (IL-17) ANTIBODIES
RELATED APPLICATIONS
The instant application claims priority to US Provisional Patent application No.
62/348217, filed June 10, 2016, which is incorporated by reference herein in its entirety.
TECHNICAL FIELD
The present disclosure relates to methods for treating vitiligo, using IL-17 antagonists, e.g., an IL-17 antibody or antigen-binding fragment thereof, such as secukinumab.
 
 
请您先登陆，再发跟帖！